Dravet Syndrome
RareNeurological
Dravet Syndrome is treated with 2 medications in our database, including Klonopin, ZTALMY. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Cheplapharm, Marinus. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Dravet Syndrome treatment below.
What help exists for Dravet Syndrome
4
drugs indexed
2
with copay cards
2
with patient assistance
1
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Dravet Syndrome
4 totalKlonopin
Clonazepam
ZTALMY
ganaxolone · Marinus
Epidiolex
cannabidiol · Jazz
🎟💙Fintepla
fenfluramine · UCB
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Dravet Syndrome drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Grants for Dravet Syndrome patients
2 total · 1 openDravet Syndrome is a rare disease — more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare →